Annual Working Capital
$950.62 M
+$48.59 M+5.39%
31 December 2023
Summary:
Vaxcyte annual working capital is currently $950.62 million, with the most recent change of +$48.59 million (+5.39%) on 31 December 2023. During the last 3 years, it has risen by +$608.47 million (+177.84%). PCVX annual working capital is now at all-time high.PCVX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$2.09 B
+$691.44 M+49.44%
30 September 2024
Summary:
Vaxcyte quarterly working capital is currently $2.09 billion, with the most recent change of +$691.44 million (+49.44%) on 30 September 2024. Over the past year, it has increased by +$880.20 million (+72.75%). PCVX quarterly working capital is now at all-time high.PCVX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCVX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.4% | +72.8% |
| 3 y3 years | +177.8% | +718.1% |
| 5 y5 years | +1485.5% | - |
PCVX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +317.6% | at high | +818.2% |
| 5 y | 5 years | at high | +1776.1% | at high | +4024.8% |
| alltime | all time | at high | +1776.1% | at high | +4024.8% |
Vaxcyte Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.09 B(+49.4%) |
| June 2024 | - | $1.40 B(-2.2%) |
| Mar 2024 | - | $1.43 B(+50.4%) |
| Dec 2023 | $950.62 M(+5.4%) | $950.62 M(-21.4%) |
| Sept 2023 | - | $1.21 B(-3.2%) |
| June 2023 | - | $1.25 B(+58.7%) |
| Mar 2023 | - | $787.93 M(-12.6%) |
| Dec 2022 | $902.03 M | $902.03 M(+173.0%) |
| Sept 2022 | - | $330.45 M(-0.8%) |
| June 2022 | - | $333.26 M(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $314.97 M(+38.4%) |
| Dec 2021 | $227.63 M(-33.5%) | $227.63 M(-10.9%) |
| Sept 2021 | - | $255.49 M(-2.0%) |
| June 2021 | - | $260.83 M(-3.3%) |
| Mar 2021 | - | $269.70 M(-21.2%) |
| Dec 2020 | $342.14 M(+575.2%) | $342.14 M(-5.3%) |
| Sept 2020 | - | $361.22 M(-5.0%) |
| June 2020 | - | $380.16 M(+183.6%) |
| Mar 2020 | - | $134.07 M(+164.6%) |
| Dec 2019 | $50.67 M(-15.5%) | $50.67 M |
| Dec 2018 | $59.95 M | - |
FAQ
- What is Vaxcyte annual working capital?
- What is the all time high annual working capital for Vaxcyte?
- What is Vaxcyte annual working capital year-on-year change?
- What is Vaxcyte quarterly working capital?
- What is the all time high quarterly working capital for Vaxcyte?
- What is Vaxcyte quarterly working capital year-on-year change?
What is Vaxcyte annual working capital?
The current annual working capital of PCVX is $950.62 M
What is the all time high annual working capital for Vaxcyte?
Vaxcyte all-time high annual working capital is $950.62 M
What is Vaxcyte annual working capital year-on-year change?
Over the past year, PCVX annual working capital has changed by +$48.59 M (+5.39%)
What is Vaxcyte quarterly working capital?
The current quarterly working capital of PCVX is $2.09 B
What is the all time high quarterly working capital for Vaxcyte?
Vaxcyte all-time high quarterly working capital is $2.09 B
What is Vaxcyte quarterly working capital year-on-year change?
Over the past year, PCVX quarterly working capital has changed by +$880.20 M (+72.75%)